Lysozyme uptake into pharmaceutical grade fucoidan/chitosan polyelectrolyte multilayers under physiological conditions

https://doi.org/10.1016/j.jcis.2020.01.030Get rights and content

Abstract

Polyelectrolyte multilayers composed of pharmaceutical grade fucoidan and chitosan have been assembled and studied in terms of their response to physiological solution conditions and the presence of lysozyme. The influence of phosphate buffered saline (PBS) solution on the multilayer was interrogated using attenuated total reflectance (ATR) Fourier transform infrared (FTIR) spectroscopy and atomic force microscopy (AFM). The combination of the techniques reveal that the polyelectrolyte multilayers swell when exposed to PBS after build-up and may include a small degree of mass loss as the film swells. The degree of swelling was influenced by the terminating layer of the multilayer. Upon exposure to lysozyme, it was observed that some deswelling occurred, as the enzyme adsorbed onto and permeated into the multilayer. The behaviour of the multilayer as a potential reservoir for lysozyme contrasts with the interaction with bovine serum albumin, which did not penetrate into the multilayer, indicating either exclusion by size or due to the overall net negative charge of the film.

Introduction

Polyelectrolyte multilayers (PEMs) are a subtype of soft matter surface coatings that can be influenced by various factors both during and after the formation of the coating, e.g. ionic strength and composition, pH, and temperature [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. These parameters effect PEM films owing to the nature of the layer-by-layer (LbL) method by which the films are produced. The LbL technique uses the interaction between the charged functional groups on polyelectrolytes to build the PEM by sequentially adsorbing layers of oppositely charged species that interact predominantly via direct ion pairing. The effect of pH and ionic strength of the background electrolyte is known to impact PEM properties [16], [17], [18], [19], [20], [21], [22], and recently several authors have investigated ion-specific effects on PEMs [23], [24], including investigating the Hofmeister series [25], [26], monovalent [13], [27] and divalent ion effects [28], [29], [30], [31] and ion transport [20], [21], [32].

In biomaterials research, PEMs intended for in vivo application are often formed in more ideal solution conditions (i.e. simpler and more dilute electrolyte composition, pH below 6) than those representative of the physiological environment (higher salt concentration, osmolarity ~0.15 M, and a pH that can vary depending on the fluid). In order to mimic physiological conditions, phosphate buffered saline (PBS) is often used as the fluid from which subsequent interactions can be studied, such as the loading of biological molecules into the PEMs [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43]. The effect of phosphate ions on synthetic and biopolymer PEMs has been investigated, with PEM films observed to become more swollen and softer in the presence of phosphate [25], [28].

For PEMs aimed towards biological applications, the impact of changing the electrolyte solution is of interest as it changes their physical properties and their ability to interact with biomolecules. In this work, we have chosen to investigate the influence of electrolyte change (between formation and physiological conditions) on the multilayer itself, and the subsequent interactions with a relevant enzyme from a biomaterials perspective. The PEM used in this work was composed of Fucus vesiculosus fucoidan, a sulfated polyanion sourced from brown seaweed, and Protosan a type of chitosan (deacetylated chitin polycation) derived from fungi. Both polymers have potential application as anti-pathogenic materials [44], [45]. Both polymers used are pharmaceutical grade materials, and therefore are ideal for the study of surface coatings that have potential for clinical applications.

The enzyme used in this work is lysozyme (LYZ), a positively charged protein of approximately 14 kDa which is predominantly found in secretory fluids, including tears [46], [47]. Lysozyme is responsible for the catalytic hydrolysis of β(1 → 4) glycosidic linkages at the C4 atom within an N-acetyl-d-glucosamine unit. These glycosidic linkages can be found within chitosan, a constituent of our PEM films. Chitosan has been shown to be degraded by lysozyme in chitosan/hyaluronic acid PEMs [48]. Fucoidan contains α(1 → 3) glycosidic linkages [49], and therefore cannot be hydrolysed by lysozyme. Catalytic hydrolysis is the reason behind the anti-bacterial nature of lysozyme; it degrades the cell wall of gram-positive bacteria through its action on peptidoglycan [47]. Creating a PEM film composed of anti-pathogenic polyelectrolytes with the ability to harvest lysozyme from tears may have an application as an antibacterial coating for contact lenses that act by exploiting and enhancing the body’s natural defenses.

To get a clear sense of the chemical and physical changes within the PEM during formation, electrolyte change, and exposure to an enzyme, we have chosen to use attenuated total reflection (ATR) FTIR. Critically, we have made use of ATR internal reflection element (IRE) materials that have allowed us to selectively study penetration and diffusion within the PEM, and separate this process from surface adsorption onto the PEM. In addition to obtaining information on the chemical changes that occur during PBS and enzyme exposure, we have used atomic force microscopy (AFM) imaging to determine the physical changes in the film, including morphology, thickness, and rigidity. These two techniques have provided a detailed picture of the evolution of the PEM during exposure to a simulated biological environment.

Section snippets

Materials

KCl (99%, AR, Chem-Supply, Australia) was purified prior to use by calcination at 550 °C for 8 h, followed by recrystallisation, and a second calcination at 550 °C. The polyelectrolytes used were: polyethylenimine (branched PEI, ≤1% water, 25 kDa, Sigma-Aldrich, Australia); pharmaceutical grade Fucus vesiculosus fucoidan (FUC, 98.0% purity, peak MW 56.9 kDa, Marinova, Australia); and Protosan UP CL 213 (chitosan or CS, 75–90% deacetylated chitin, 150–400 kDa, NovaMatrix, Norway). Protein

Multilayer build-up

ATR FTIR spectroscopy was used to monitor the build-up of a 10 bilayer fucoidan/chitosan PEM on an anchoring layer of PEI. A 9.5 bilayer PEM has a terminating layer of fucoidan whilst a 10 bilayer PEM is terminated by chitosan. The build-up data is presented in Fig. 1. The characteristic peaks of fucoidan and chitosan can be clearly seen during build-up. The peak positions have been assigned in our previous work [61], [62]. In brief, the characteristic peaks within the build-up spectra are: the

Discussion

The data presented above contains three important results that have some significance for studies of the exposure of multilayers to phosphate buffered saline and to protein solutions. First, PBS exposure causes the fucoidan/chitosan multilayers to swell and potentially lose mass. Second, the larger BSA molecule is unable to permeate into the multilayer, whilst the smaller LYZ molecule can diffuse into and remain bound within the film. Third, the diffusion of LYZ into the PEM causes deswelling.

Conclusions

This work has shown that PEMs composed of fucoidan and chitosan swell and lose mass when exposed to PBS solution after build-up. The swelling was hypothesised to be primarily caused by the presence of the divalent HPO42− ions in PBS, but also due to the ionic strength and pH changes experienced by the PEMs. This was shown via interpretation of ATR FTIR spectra of the PEMs and corresponding AFM measurements. Furthermore, these same fucoidan/chitosan PEM films were exposed to solutions of LYZ and

CRediT authorship contribution statement

Natalie L. Benbow: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing - original draft, Writing - review & editing, Visualization. Damien A. Sebben: Validation, Formal analysis, Investigation, Writing - review & editing, Visualization. Samuel Karpiniec: Resources, Writing - review & editing. Damien Stringer: Resources, Writing - review & editing. Marta Krasowska: Conceptualization, Methodology, Validation, Formal analysis, Investigation,

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The authors would like to acknowledge the support of the Australian Government’s Cooperative Research Centres Program. This work was performed in part at the South Australian node of the Australian National Fabrication Facility, a company established under the National Collaborative Research Infrastructure Strategy to provide nano and micro-fabrication facilities for Australia’s researchers. DAB acknowledges the financial support from the Australian Research Council (ARC: Future Fellowship

References (78)

  • S.M. Oliveira et al.

    Layer-by-layer assembled cell instructive nanocoatings containing platelet lysate

    Biomaterials

    (2015)
  • R. Jayakumar et al.

    Biomaterials based on chitin and chitosan in wound dressing applications

    Biotechnol. Adv.

    (2011)
  • A.M. McDermott

    Antimicrobial compounds in tears

    Exp. Eye Res.

    (2013)
  • M.D. Yilmaz

    Layer-by-layer hyaluronic acid/chitosan polyelectrolyte coated mesoporous silica nanoparticles as pH-responsive nanocontainers for optical bleaching of cellulose fabrics

    Carbohydr. Polym.

    (2016)
  • J.L. Webber et al.

    Formation and enzymatic degradation of poly-l-arginine/fucoidan multilayer films

    Colloids Surf., B

    (2017)
  • K. Laos et al.

    The adsorption of globular proteins, bovine serum albumin and β-lactoglobulin, on poly-l-lysine-furcellaran multilayers

    Carbohydr. Polym.

    (2006)
  • N.L. Benbow et al.

    Odd-even effects on hydration of natural polyelectrolyte multilayers: an in situ synchrotron FTIR microspectroscopy study

    J. Colloid Interface Sci.

    (2019)
  • B. Batas et al.

    Studies of the hydrodynamic volume changes that occur during refolding of lysozyme using size-exclusion chromatography

    J. Chromatogr. A

    (1997)
  • K. Tomihata et al.

    In vitro and in vivo degradation of films of chitin and its deacetylated derivatives

    Biomaterials

    (1997)
  • U.K. Aravind et al.

    Transport studies of BSA, lysozyme and ovalbumin through chitosan/polystyrene sulfonate multilayer membrane

    J. Membr. Sci.

    (2007)
  • J. Mathew et al.

    Effect of ionic strength and protein concentration on the transport of proteins through chitosan/polystyrene sulfonate multilayer membrane

    J. Membr. Sci.

    (2008)
  • J. Mathew et al.

    Fabrication of switchable protein resistant and adhesive multilayer membranes

    Colloids Surf., B

    (2012)
  • A.D. Cramer et al.

    The influence of polyanion molecular weight on polyelectrolyte multilayers at surfaces: elasticity and susceptibility to saloplasticity of strongly dissociated synthetic polymers at fluid-fluid interfaces

    Phys. Chem. Chem. Phys.

    (2017)
  • J.E. Wong et al.

    Specific ion versus electrostatic effects on the construction of polyelectrolyte multilayers

    Langmuir

    (2009)
  • S. Dodoo et al.

    Effect of ionic strength and type of ions on the structure of water swollen polyelectrolyte multilayers

    Phys. Chem. Chem. Phys.

    (2011)
  • V. Ball et al.

    Effect of thiocyanate counterion condensation on poly(allylamine hydrochloride) chains on the buildup and permeability of polystyrenesulfonate/ polyallylamine polyelectrolyte multilayers

    Langmuir

    (2005)
  • X. Wang et al.

    Conformational behavior of grafted weak polyelectrolyte chains: effects of counterion condensation and nonelectrostatic anion adsorption

    Langmuir

    (2011)
  • L. Ghimici et al.

    Behaviour of cationic polyelectrolytes upon binding of electrolytes: effects of polycation structure, counterions and nature of the solvent

    Colloid Polym. Sci.

    (2002)
  • R. Shahlori et al.

    Biomineralization of calcium phosphate and calcium carbonate within iridescent chitosan/iota-carrageenan multilayered films

    Langmuir

    (2018)
  • Q. Guo et al.

    Tuning ice nucleation and propagation with counterions on multilayer hydrogels

    Langmuir

    (2018)
  • J.T. O'Neal et al.

    QCM-D investigation of swelling behavior of layer-by-layer thin films upon exposure to monovalent ions

    Langmuir

    (2018)
  • S.T. Dubas et al.

    Factors controlling the growth of polyelectrolyte multilayers

    Macromolecules

    (1999)
  • S.T. Dubas et al.

    Swelling and smoothing of polyelectrolyte multilayers by salt

    Langmuir

    (2001)
  • H.M. Fares et al.

    Diffusion of sites versus polymers in polyelectrolyte complexes and multilayers

    J. Am. Chem. Soc.

    (2017)
  • T. Farhat et al.

    Water and ion pairing in polyelectrolyte multilayers

    Langmuir

    (1999)
  • T.R. Farhat et al.

    Doping-controlled ion diffusion in polyelectrolyte multilayers: mass transport in reluctant exchangers

    J. Am. Chem. Soc.

    (2003)
  • R.A. Ghostine et al.

    Ion diffusion coefficients through polyelectrolyte multilayers: temperature and charge dependence

    Langmuir

    (2011)
  • H.W. Jomaa et al.

    Salt-induced polyelectrolyte interdiffusion in multilayered films: a neutron reflectivity study

    Macromolecules

    (2005)
  • G. Liu

    Tuning the properties of charged polymers at the solid/liquid interface with ions

    Langmuir

    (2018)
  • Cited by (15)

    • ATR FTIR spectroscopy of protein and surfactant adsorption to the oil-water interface

      2023, Colloids and Surfaces A: Physicochemical and Engineering Aspects
    • Marine origin biomaterials using a compressive and absorption methodology as cell-laden hydrogel envisaging cartilage tissue engineering

      2022, Biomaterials Advances
      Citation Excerpt :

      On the other hand, fucoidan is a sulfated polysaccharide not available also in the human body (neither its specific enzyme, fucoidanase) but sharing a structural composition with sulfated glycosaminoglycans (GAG's), namely chondroitin sulfates [87]. Unfortunately, fucoidan cannot be hydrolyzed by lysozyme since it contains α(1-3) glycosidic linkages in its structure instead of (1-4) glycosidic linkages [88]. Additionally, human body doesn't have enzymatic capacity to promote the degradation of fucoidan but it is known that some fucoidan samples can inhibit the action of hyaluronidase [89], from which we used the lysozyme to act on chitosan in case of the hyaluronidase stay inactive.

    • Recent advances in chitosan-based layer-by-layer biomaterials and their biomedical applications

      2021, Carbohydrate Polymers
      Citation Excerpt :

      The versatility of LBL facilitates the loading of drugs into chitosan-based composites. Chitosan-based drug cargos could be used for drugs which are poorly soluble in aqueous conditions (Jeon, Yoo, & Park, 2015; Wang, Li, Tang, Huang, & Chen, 2020), acid-susceptible (Huang, Zhang, Cheng, & Xiao, 2019; Wang et al., 2019; Zhang et al., 2021), electronically charged (Rocha Neto et al., 2021; Schipper et al., 2017; Speth, Repnik, & Griffiths, 2016), active biological molecules (e.g., growth factors (Romero et al., 2017), cytokines (Kristo et al., 2020)), antibiotics (Esmaeili & Khodaei, 2018), proteins (Benbow et al., 2020; Yang, Zhu, Wang, Fang, & Peng, 2018), microorganisms (Quintana et al., 2017)) or other active chemicals (Jamshidzadeh, Mohebali, & Abdouss, 2020; Janardhanam, Indukuri, Verma, Dusane, & Venuganti, 2020; Liu et al., 2019b; Suh, Shen, Kuhn, & Burgess, 2017; Wang et al., 2020b) for the treatment of tumors (e.g., human breast tumor (Jardim et al., 2018)) and cancers (e.g., malari (Bhalerao, Valiveti, Acharya, Halve, & Kaushik, 2015), melanoma (Labala et al., 2017; Labala, Jose, & Venuganti, 2016), cervical cancer (Moreira et al., 2020a)). The decomposition of the drug vehicles induces the release of encapsulated drugs (Huang, Zhang, Cheng, & Xiao, 2019; Yang, Zhu, Wang, Fang, & Peng, 2018).

    • Development of a new method for isolation of urban air particulates deposited in the human lung tissue

      2021, Chemosphere
      Citation Excerpt :

      The separated PMs should be cleaned up free of surfactant residue to prevent crystal formation in microscopy samples. An agent such as PBS leads to particle agglomeration (Benbow et al., 2020), which is against the aim of this study, where we aimed at the highest dispersion and resuspension of PMs. Second, by using a mixture of acellularization agents can damage the ECM, as some reports claimed (Pridgen et al., 2011; Petersen et al., 2012).

    View all citing articles on Scopus
    View full text